Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality
- PMID: 28410410
- PMCID: PMC5391945
- DOI: 10.1371/journal.pone.0175794
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide. There is evidence to support a connection between COPD and diabetes mellitus (DM), another common medical disorder. However, additional research is required to improve our knowledge of these relationships and their possible implications. In this study, we investigated the impact of DM on patient outcomes through the clinical course of COPD.
Methods: We conducted a cohort study in patients from the Taiwan Longitudinal Health Insurance Database between 2000 and 2013. Patients with COPD were identified and assessed for pre-existing and incident DM. A Cox proportional hazards model was built to identify factors associated with incident DM and to explore the prognostic effects of DM on COPD patients. A propensity score method was used to match COPD patients with incident DM to controls without incident DM.
Results: Pre-existing DM was present in 332 (16%) of 2015 COPD patients who had a significantly higher hazard ratio (HR) [1.244, 95% confidence interval (CI) 1.010-1.532] for mortality than that of the COPD patients without pre-existing DM. During the 10-year follow-up period, 304 (19%) of 1568 COPD patients developed incident DM; comorbid hypertension (HR, 1.810; 95% CI, 1.363-2.403), cerebrovascular disease (HR, 1.517; 95% CI, 1.146-2.008) and coronary artery disease (HR, 1.408; 95% CI 1.089-1.820) were significant factors associated with incident DM. Survival was worse for the COPD patients with incident DM than for the matched controls without incident DM (Log-rank, p = 0.027).
Conclusions: DM, either pre-existing or incident, was associated with worse outcomes in COPD patients. _targeted surveillance and management of DM may be important in clinical care of the COPD population.
Conflict of interest statement
Figures
Similar articles
-
Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study.Eur J Clin Invest. 2013 Nov;43(11):1113-9. doi: 10.1111/eci.12147. Epub 2013 Sep 12. Eur J Clin Invest. 2013. PMID: 24028296
-
Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study.Alzheimers Res Ther. 2017 Feb 6;9(1):7. doi: 10.1186/s13195-017-0236-z. Alzheimers Res Ther. 2017. PMID: 28162091 Free PMC article.
-
Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation.COPD. 2016;13(1):50-6. doi: 10.3109/15412555.2015.1043425. Epub 2015 Sep 14. COPD. 2016. PMID: 26366936
-
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.Cardiovasc Diabetol. 2012 Oct 27;11:132. doi: 10.1186/1475-2840-11-132. Cardiovasc Diabetol. 2012. PMID: 23101436 Free PMC article. Review.
-
The interplay between diabetes mellitus and chronic obstructive pulmonary disease.Minerva Med. 2023 Feb;114(1):68-73. doi: 10.23736/S0026-4806.22.07742-4. Epub 2022 Feb 9. Minerva Med. 2023. PMID: 35138076 Review.
Cited by
-
Hyperglycaemia and Chronic Obstructive Pulmonary Disease.Diagnostics (Basel). 2023 Nov 1;13(21):3362. doi: 10.3390/diagnostics13213362. Diagnostics (Basel). 2023. PMID: 37958258 Free PMC article. Review.
-
Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort.J Clin Med. 2023 Oct 20;12(20):6636. doi: 10.3390/jcm12206636. J Clin Med. 2023. PMID: 37892775 Free PMC article.
-
All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD).Int J Chron Obstruct Pulmon Dis. 2023 Jun 13;18:1207-1218. doi: 10.2147/COPD.S407085. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37332839 Free PMC article.
-
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2023 Feb 15;18:129-137. doi: 10.2147/COPD.S393323. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 36815056 Free PMC article. Review.
-
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.BMJ. 2022 Nov 1;379:e071380. doi: 10.1136/bmj-2022-071380. BMJ. 2022. PMID: 36318979 Free PMC article.
References
-
- Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. 10.1016/S0140-6736(15)60692-4 - DOI - PMC - PubMed
-
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. http://goldcopd.org.
-
- Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40. 10.1016/S0140-6736(11)60679-X - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical